Lester Steven Kritzer, MD | |
935 Main St, Level B, Manchester, CT 06040-6059 | |
(860) 649-0233 | |
Not Available |
Full Name | Lester Steven Kritzer |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 47 Years |
Location | 935 Main St, Manchester, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245206663 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 022080 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Manchester Memorial Hospital | Manchester, CT | Hospital |
Mailing Address | Practice Location Address |
---|---|
Lester Steven Kritzer, MD 935 Main St, Level B, Manchester, CT 06040-6059 Ph: (860) 649-0233 | Lester Steven Kritzer, MD 935 Main St, Level B, Manchester, CT 06040-6059 Ph: (860) 649-0233 |
News Archive
It's a tragic news story that often makes headlines - a young, healthy, fit athlete suddenly collapses and dies of cardiac arrest while playing sports.
An international study led by a Johns Hopkins pulmonary expert finds that the drug tiotropium (marketed as the Spiriva brand), can be delivered safely and effectively to people with chronic obstructive pulmonary disease (COPD) in both "mist" and traditional "dry powder" inhalers.
A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA - so-called epigenetic changes - to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute.
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.
Members of the public are being invited to Queen's University at lunchtime on Thursday (13 September) to meet and hear from the people behind some of the biggest scientific, medical and technological breakthroughs of recent times.
› Verified 3 days ago
Dr. Joseph Francis Mclaughlin, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Haynes St, Second Floor, Manchester, CT 06040 Phone: 860-646-0670 Fax: 860-643-9388 | |
Prof. Hazar Dahhan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 201 Main St, Manchester, CT 06042 Phone: 860-643-5443 Fax: 860-643-9399 | |
Dr. Sun King Wan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 257 E Center St, Manchester, CT 06040 Phone: 860-643-5101 Fax: 860-533-9747 | |
Dr. Angelee Carta, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 515 Middle Tpke W, Manchester, CT 06040 Phone: 860-533-4176 Fax: 860-649-5092 | |
Dr. Alejandro Murcia, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 483 W Middle Tpke, Suite 300, Manchester, CT 06040 Phone: 860-430-1213 Fax: 860-533-3420 | |
Dr. Joseph Hanna, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 18 Haynes St, Manchester, CT 06040 Phone: 860-649-7557 | |
Peter S Buch, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 353 Main St, Manchester, CT 06040 Phone: 860-649-3477 Fax: 860-649-0011 |